These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 31208818)
1. Central nervous system vasculitis from Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children: A case report. Lee MS; Hwang SK; Kim YE; Suh JK; Kim H; Lee SM; Jeong JY; Kwon S; Lee YJ Brain Dev; 2019 Oct; 41(9):820-825. PubMed ID: 31208818 [TBL] [Abstract][Full Text] [Related]
2. Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report. Yamamoto M; Shindo M; Sumi C; Igarashi S; Saito T; Tsukada N; Toki Y; Hatayama M; Inamura J; Sato K; Mizukami Y; Torimoto Y; Okumura T Medicine (Baltimore); 2021 Apr; 100(16):e25518. PubMed ID: 33879690 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report. Xiao HJ; Li J; Song HM; Li ZH; Dong M; Zhou XG Medicine (Baltimore); 2016 Feb; 95(5):e2676. PubMed ID: 26844502 [TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407 [TBL] [Abstract][Full Text] [Related]
5. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis. Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Hue SS; Oon ML; Wang S; Tan SY; Ng SB Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131 [TBL] [Abstract][Full Text] [Related]
8. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect. Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820 [TBL] [Abstract][Full Text] [Related]
9. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma. Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563 [TBL] [Abstract][Full Text] [Related]
10. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder]. Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338 [TBL] [Abstract][Full Text] [Related]
12. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative disease. Koyama M; Takeshita Y; Sakata A; Sawada A; Yasui M; Okamura T; Inoue M; Kawa K Int J Hematol; 2005 Dec; 82(5):437-40. PubMed ID: 16533748 [TBL] [Abstract][Full Text] [Related]
14. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder. Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419 [TBL] [Abstract][Full Text] [Related]
15. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease]. Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280 [No Abstract] [Full Text] [Related]
16. Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease. Kawa K Int J Hematol; 2003 Jul; 78(1):24-31. PubMed ID: 12894847 [TBL] [Abstract][Full Text] [Related]
17. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Kimura H; Ito Y; Kawabe S; Gotoh K; Takahashi Y; Kojima S; Naoe T; Esaki S; Kikuta A; Sawada A; Kawa K; Ohshima K; Nakamura S Blood; 2012 Jan; 119(3):673-86. PubMed ID: 22096243 [TBL] [Abstract][Full Text] [Related]
18. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder. Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925 [TBL] [Abstract][Full Text] [Related]